{
    "nctId": "NCT02583828",
    "briefTitle": "Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients",
    "officialTitle": "N/A",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Neoplasm Metastasis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Progression free survival(PFS) of the subjects",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed metastatic breast cancers patients with estrogen receptor positive and/or progesterone receptor positive;\n* Elderly women (age \u2265 65years)\n* Failure or relapse from standard chemotherapy or unfit for chemotherapy\n* Measurable disease per Response Evaluation Criteria in Solid Tumors(RECIST);\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2;\n* Adequate bone marrow, liver and renal function;\n* Estimated life expectancy of at least 3 months.\n\nExclusion Criteria:\n\n* Serious or uncontrolled concurrent medical illness\n* Uncontrolled primary and metastatic brain tumor\n* History of second primary malignancies\n* Having been enrolled in other clinical trials within a month",
    "sex": "FEMALE",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}